Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM)
QNTM trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.89
+2.48% on the day
Market cap
$24.5M
Nano cap
Revenue
No annual revenue filed since the period ending 2019-12-31
Net income
No annual revenue filed since the period ending 2019-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | QNTM on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001771885 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A6 |
Financials
No annual revenue filed since the period ending 2019-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-12-22 |
| Latest annual report FORM 20-F | 20-F | 2026-03-26 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-08 |
Source: SEC EDGAR submissions feed, 356 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SHPH | Shuttle Pharmaceuticals Holdings Inc. | $5.18 | -4.95% | $24.7M |
| PBM | Psyence Biomedical Ltd. Common Shares | $4.55 | -4.01% | $24.2M |
| BYSI | BeyondSpring Inc. | $0.6067 | -1.43% | $24.9M |
| KYNB | Kyntra Bio Inc. | $5.87 | -4.08% | $23.8M |
| CNTX | Context Therapeutics Inc. | $0.2750 | -9.84% | $25.3M |
| MCRB | Seres Therapeutics Inc. | $2.53 | -5.60% | $25.4M |
| ATOS | Atossa Therapeutics Inc. | $2.56 | +7.17% | $25.5M |
| ABVC | ABVC BioPharma Inc. | $0.9790 | -0.08% | $26.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier